These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Niacin stimulates adiponectin secretion through the GPR109A receptor. Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678 [TBL] [Abstract][Full Text] [Related]
4. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. Taggart AK; Kero J; Gan X; Cai TQ; Cheng K; Ippolito M; Ren N; Kaplan R; Wu K; Wu TJ; Jin L; Liaw C; Chen R; Richman J; Connolly D; Offermanns S; Wright SD; Waters MG J Biol Chem; 2005 Jul; 280(29):26649-52. PubMed ID: 15929991 [TBL] [Abstract][Full Text] [Related]
5. Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A. Zhang Y; Schmidt RJ; Foxworthy P; Emkey R; Oler JK; Large TH; Wang H; Su EW; Mosior MK; Eacho PI; Cao G Biochem Biophys Res Commun; 2005 Aug; 334(2):729-32. PubMed ID: 16018973 [TBL] [Abstract][Full Text] [Related]
6. Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid. Pike NB J Clin Invest; 2005 Dec; 115(12):3400-3. PubMed ID: 16322787 [TBL] [Abstract][Full Text] [Related]
7. 3,5-Dihydroxybenzoic acid, a specific agonist for hydroxycarboxylic acid 1, inhibits lipolysis in adipocytes. Liu C; Kuei C; Zhu J; Yu J; Zhang L; Shih A; Mirzadegan T; Shelton J; Sutton S; Connelly MA; Lee G; Carruthers N; Wu J; Lovenberg TW J Pharmacol Exp Ther; 2012 Jun; 341(3):794-801. PubMed ID: 22434674 [TBL] [Abstract][Full Text] [Related]
9. Characterization of determinants of ligand binding to the nicotinic acid receptor GPR109A (HM74A/PUMA-G). Tunaru S; Lättig J; Kero J; Krause G; Offermanns S Mol Pharmacol; 2005 Nov; 68(5):1271-80. PubMed ID: 16099840 [TBL] [Abstract][Full Text] [Related]
10. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Lauring B; Taggart AK; Tata JR; Dunbar R; Caro L; Cheng K; Chin J; Colletti SL; Cote J; Khalilieh S; Liu J; Luo WL; Maclean AA; Peterson LB; Polis AB; Sirah W; Wu TJ; Liu X; Jin L; Wu K; Boatman PD; Semple G; Behan DP; Connolly DT; Lai E; Wagner JA; Wright SD; Cuffie C; Mitchel YB; Rader DJ; Paolini JF; Waters MG; Plump A Sci Transl Med; 2012 Aug; 4(148):148ra115. PubMed ID: 22914621 [TBL] [Abstract][Full Text] [Related]
11. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents? Kamanna VS; Kashyap ML Am J Cardiol; 2007 Dec; 100(11 A):S53-61. PubMed ID: 18047854 [TBL] [Abstract][Full Text] [Related]
12. Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium. Martin PM; Ananth S; Cresci G; Roon P; Smith S; Ganapathy V Mol Vis; 2009; 15():362-72. PubMed ID: 19223991 [TBL] [Abstract][Full Text] [Related]
13. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Ge H; Li X; Weiszmann J; Wang P; Baribault H; Chen JL; Tian H; Li Y Endocrinology; 2008 Sep; 149(9):4519-26. PubMed ID: 18499755 [TBL] [Abstract][Full Text] [Related]
14. Overexpressing human GPR109A leads to pronounced reduction in plasma triglyceride levels in BAC transgenic rats. Masuda Y; Kurikawa N; Nishizawa T Atherosclerosis; 2018 May; 272():182-192. PubMed ID: 29625294 [TBL] [Abstract][Full Text] [Related]
15. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Tunaru S; Kero J; Schaub A; Wufka C; Blaukat A; Pfeffer K; Offermanns S Nat Med; 2003 Mar; 9(3):352-5. PubMed ID: 12563315 [TBL] [Abstract][Full Text] [Related]
16. Differential tissue and ligand-dependent signaling of GPR109A receptor: implications for anti-atherosclerotic therapeutic potential. Gaidarov I; Chen X; Anthony T; Maciejewski-Lenoir D; Liaw C; Unett DJ Cell Signal; 2013 Oct; 25(10):2003-16. PubMed ID: 23770183 [TBL] [Abstract][Full Text] [Related]
17. Nicotinic acid receptor subtypes and their ligands. Soudijn W; van Wijngaarden I; Ijzerman AP Med Res Rev; 2007 May; 27(3):417-33. PubMed ID: 17238156 [TBL] [Abstract][Full Text] [Related]
18. Nicotinic Acid Receptor GPR109A Exerts Anti-Inflammatory Effects Through Inhibiting the Akt/mTOR Signaling Pathway in MIN6 Pancreatic β cells. Li Z; Li X; Lin S; Chen Y; Ma S; Fu Y; Wei C; Xu W Ann Clin Lab Sci; 2017 Nov; 47(6):729-737. PubMed ID: 29263047 [TBL] [Abstract][Full Text] [Related]
19. Novel 3,6,7-substituted pyrazolopyrimidines as positive allosteric modulators for the hydroxycarboxylic acid receptor 2 (GPR109A). Blad CC; van Veldhoven JP; Klopman C; Wolfram DR; Brussee J; Lane JR; Ijzerman AP J Med Chem; 2012 Apr; 55(7):3563-7. PubMed ID: 22420767 [TBL] [Abstract][Full Text] [Related]
20. The role of HCA2 (GPR109A) in regulating macrophage function. Zandi-Nejad K; Takakura A; Jurewicz M; Chandraker AK; Offermanns S; Mount D; Abdi R FASEB J; 2013 Nov; 27(11):4366-74. PubMed ID: 23882124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]